US 11,988,678 B2
Test strips for determining coagulation factor activities
Bernat Galmés Sureda, Palma de Mallorca (ES); Mariana Isabel Canaro Hirnyk, Palma de Mallorca (ES); and Vicente R. Cortina Giner, Palma de Mallorca (ES)
Assigned to CGT ENTERPRISES, LLC, Laguna Niguel, CA (US)
Filed by CGT Enterprises, LLC, Laguna Niguel, CA (US)
Filed on Feb. 26, 2021, as Appl. No. 17/187,460.
Application 17/187,460 is a continuation of application No. 16/550,767, filed on Aug. 26, 2019, granted, now 10,969,397.
Application 16/550,767 is a continuation of application No. 15/483,876, filed on Apr. 10, 2017, granted, now 10,436,805, issued on Oct. 8, 2019.
Application 15/483,876 is a continuation of application No. 14/891,119, granted, now 9,651,567, issued on May 16, 2017, previously published as PCT/EP2014/053461, filed on Feb. 21, 2014.
Claims priority of application No. ES201330983 (ES), filed on May 14, 2013.
Prior Publication US 2021/0293832 A1, Sep. 23, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. B01L 3/00 (2006.01); C12Q 1/56 (2006.01); G01N 33/86 (2006.01)
CPC G01N 33/86 (2013.01) [B01L 3/502 (2013.01); C12Q 1/56 (2013.01); B01L 3/5027 (2013.01); B01L 2300/024 (2013.01); B01L 2300/0825 (2013.01); B01L 2300/0838 (2013.01); B01L 2300/0864 (2013.01); G01N 2333/7454 (2013.01)] 25 Claims
OG exemplary drawing
 
1. A cartridge comprising:
(a) a sample inlet port configured to receive a blood sample;
(b) a first compartment configured to receive at least a portion of said blood sample from said sample inlet port, wherein said first compartment contains an ionic citrate source configured to produce citrated blood upon contacting said at least said portion of said blood sample; and
(c) a second compartment that contains a depleted plasma that is depleted of a coagulation factor, wherein said second compartment is in fluidic communication with said first compartment and is configured to receive at least a portion of said citrated blood.